Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)
Trial details
- Registry ID
- NCT07146022
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)NCT07146022 | MANE | Phase 3 | Active not recruiting | 2027-06Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |